RUBINSTEIN JULIE (President and COO at Adaptive Biotechnologies Corp) acquired (option exercise) 11,881 shares at $12.14/share on 2026-10-06 (9 transactions total in this filing) [FILING TOTAL: $948,223 sold]. [10b5-1 SCHEDULED PLAN]